8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence

It was previously reported the safety and efficacy of oral tapentadol ER switched from other opioids for 8 weeks in subjects with moderate to severe cancer pain, who received opioid analgesics prior to study participation. All treatment emergent adverse events were evaluated in previous safety analy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Palliative Care Research 2016, Vol.11(1), pp.116-122
Hauptverfasser:	Imanaka, Keiichiro, Yoshimura, Takashi, Tominaga, Yushin, Koga, Hiromi, Hirose, Keiichiro
Format:	Artikel
Sprache:	eng ; jpn
Schlagworte:	gastrointestinal disorders opioid somnolence tapentadol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!